Clinical trial
Long Term Eslicarbazepine Acetate Extension Study
NCT00910247 is registered in ClinicalTrials.gov with Sumitomo Pharma America, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Eslicarbazepine Acetate Extension Study
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- April 15, 2017
- Enrollment
- 274 (actual)
- Sites
- 122
Conditions
As the registry lists them; a condition with its own page is linked.